|
|
Volumn 10, Issue 3, 2011, Pages 213-217
|
|
On assessing the presence of evaluation-time bias in progression-free survival in randomized trials
a
|
|
Author keywords
logrank test; progression free survival; simulation
|
|
Indexed keywords
DACARBAZINE;
OBLIMERSEN;
ARTICLE;
CLINICAL EVALUATION;
CLINICAL FEATURE;
CLINICAL PRACTICE;
COMBINATION CHEMOTHERAPY;
COMPUTER SIMULATION;
CONTINUOUS INFUSION;
DISEASE COURSE;
FOLLOW UP;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
MELANOMA;
MONOTHERAPY;
MULTIPLE CYCLE TREATMENT;
OUTCOME ASSESSMENT;
PROGRESSION FREE SURVIVAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SENSITIVITY ANALYSIS;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, ALKYLATING;
BIAS (EPIDEMIOLOGY);
COMPUTER SIMULATION;
DACARBAZINE;
DISEASE-FREE SURVIVAL;
HUMANS;
KAPLAN-MEIER ESTIMATE;
MELANOMA;
MODELS, THEORETICAL;
OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE);
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
REPRODUCIBILITY OF RESULTS;
RESEARCH DESIGN;
THIONUCLEOTIDES;
TIME FACTORS;
TREATMENT OUTCOME;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 79956158520
PISSN: 15391604
EISSN: 15391612
Source Type: Journal
DOI: 10.1002/pst.443 Document Type: Article |
|
Times cited : (7)
|
|
References (9)
|
